ScubaTx Limited

ScubaTx is a development stage spin-out company from Newcastle University and Newcastle Upon Tyne Hospitals NHS Foundation Trust. Their mission is to commercialize a proven but unexploited organ preservation technique, Persufflation, through their ScubaTx™ device. This device aims to address the critical need for a safe, effective, and affordable solution to maintain organ viability for extended periods, thereby increasing the pool of life-giving organs for transplantation.

ScubaTx leverages expertise in software design to create their automated persufflation system. This system comprises a portable, multi-organ base unit and organ-specific consumables, ensuring compatibility with various organ types. ScubaTx also offers a mobile application to provide real-time feedback on organ status, streamlining the transplant process and enhancing the quality of organ preservation.

ScubaTx Limited is a medical technology company developing a novel organ preservation system called the ScubaTx™ device. The company's mission is to revolutionize organ transplantation by providing a more efficient, cost-effective, and accessible method of preserving organs. The ScubaTx™ device utilizes a technology called Persufflation, which involves submerging organs in cold saline and perfusing oxygen-rich gas through their vasculature. This approach aims to significantly extend the preservation time of organs, reduce the number of organs that go unused, and improve the quality of organs available for transplantation. ScubaTx Limited is committed to improving the lives of patients in need of organ transplantation and alleviating the global organ shortage.

ScubaTx promotes a culture of innovation and collaboration, driven by a shared passion for improving organ preservation and transplant outcomes. They emphasize a strong focus on research and development, with a team composed of world-renowned experts in their fields. The company values a collaborative approach to problem-solving, bringing together diverse perspectives to achieve their goals. Their mission is to unlock the full potential of organ transplant therapy, and this commitment permeates their work and the atmosphere they foster.